Diabetes Mellitus, Type 2: all 9,590 studies
Page 67 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Study of HTD4010 in Healthy VolunteersCompletedNCT02538848Phase 1
- Tofogliflozin GLP-1 Analogue Combination TrialCompletedNCT02537834Phase 4
- Safety and Efficacy of Biphasic Remogliflozin Etabonate in the Treatment of Type 2 DiabetesCompletedNCT02537470Phase 2
- Psychoneuroimmunology Therapy in Uncontrolled Diabetic Patients: A Quasi-experimental StudyStatus unknownNCT02536820Phase 3
- Lifestyle-Related Health Outcomes in Prediabetes and DiabetesCompletedNCT02535169Not applicable
- Role of Allopurinol on Oxidative Stress and Mitochondrial Alterations in Skeletal Muscle of Diabetic PatientsCompletedNCT02533648Phase 3
- Human Intestinal Peptides Evaluation and ResearchStatus unknownNCT02532829
- Modulating Effects of Oil Palm Phenolics in Uncontrolled Insulin-treated Type 2 Diabetes MellitusTerminatedNCT02532101Not applicable
- Patient Experiences With Injection NeedlesCompletedNCT02531776Not applicable
- Curcumin Supplementation and Patients With Type 2 DiabetesCompletedNCT02529982Not applicable
- Effects of Curcumin Supplementation on Lipid Profile and Inflammatory Markers of Patients With Type 2 DiabetesStatus unknownNCT02529969Phase 2/3
- Adipose Tissue Imaging in Type 2 DiabetesCompletedNCT02528695Not applicable
- Comparison of Glycaemic Fluctuation and Oxidative Stress Between Two Short-term Therapies for Type 2 DiabetesStatus unknownNCT02526810Phase 4
- Effects of Rosiglitazone and Metformin on Metabolism in Type 2 DiabetesCompletedNCT02526615Phase 4
- Dietary Polyphenols and Glycation in Renal InsufficiencyTerminatedNCT02524938Not applicable
- A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 DiabetesCompletedNCT02524782Phase 1
- The Effect of 3 Different Models of MNT on DM Control in Overweight Patients With T2DMCompletedNCT02520050Not applicable
- Dietary Intervention in Type-2 Diabetes and Pre-DiabetesCompletedNCT02519309Not applicable
- Validation of the Doubly Labelled Water Method in Subjects With Type 2 Diabetes MellitusCompletedNCT02518581Not applicable
- High Potency Statins and the Risk of DiabetesCompletedNCT02518503
- Wine Consumption and Glycemic ControlCompletedNCT02518334Not applicable
- A Trial to Compare the Pharmacodynamic and Pharmacokinetic Properties of Biochaperone® Combo With Humalog® Mix25 and With Simultaneous Injections of Humalog® and Lantus® in Subjects With Type 2 DiabetesCompletedNCT02514850Phase 1
- Diabetes Screening & Prevention for People With Learning (Intellectual) Disabilities:STOP Diabetes StudyCompletedNCT02513277
- Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)CompletedNCT02512523Phase 4
- Effects of Neuro-myo-electrical Stimulation on Insulin Sensitivity in Patients With Type 2 DiabetesCompletedNCT02510521Not applicable
- The Effect of Administration of Small Doses of Thyroxine on Glucose and Lipid Metabolism, in Type 2 Diabetes Mellitus.CompletedNCT02509858Not applicable
- Glucose Response, Excursions And Treatment (GREAT) StudyCompletedNCT02506296Not applicable
- Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 DiabetesCompletedNCT02505308Not applicable
- Online Support for Diabetes Self-ManagementTerminatedNCT02504086Not applicable
- BDPP Treatment for Mild Cognitive Impairment (MCI) and Prediabetes or Type 2 Diabetes Mellitus (T2DM)CompletedNCT02502253Phase 1
- Type 2 Diabetes Mellitus as Catalyst for Alzheimer's DiseaseCompletedNCT02501876
- The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)Status unknownNCT02501850Phase 4
- Effect of Dapagliflozine on Systemic and Renal Endothelial FunctionStatus unknownNCT02501616Phase 4
- Alkaline Diet for Insulin SensitivityCompletedNCT02501343Not applicable
- The Role of Arachidonic Acid Metabolites, From Patients With Metabolic SyndromeStatus unknownNCT02498119
- Effect of Metformin and Cholecystokinin-mediated Gallbladder Emptying on GLP-1 Secretion in Type 2 DiabetesCompletedNCT02497313Not applicable
- Implementation of A Patient Centered Self-Management Program for Patients With Type 2 DiabetesCompletedNCT02497170Not applicable
- Mitigation of Type 2 Diabetes by Partial Ileal BypassWithdrawnNCT02493374
- Form of Dairy Products on Satiety, Food Intake and Post-meal Glycaemia in Young and Older AdultsCompletedNCT02491801Not applicable
- Closed-loop Control of Glucose Levels (Artificial Pancreas) for 24 Hours in Adults With Type 2 Diabetes Under Intensive Insulin TherapyCompletedNCT02490085Phase 2
- Early Sleeve Gastrectomy In New Onset Diabetic Obese PatientsActive, not recruitingNCT02488733Not applicable
- GLUCOME USABILITY STUDYWithdrawnNCT02488278Not applicable
- Effect of Nutritional Counseling Based on Diet Quality on Metabolic Control in Patients With Type 2 Diabetes MellitusStatus unknownNCT02488213Not applicable
- A Study of the Impact of Genetic Testing on Clinical Decision Making and Patient CareStatus unknownNCT02487888Not applicable
- Complications in Central American Diabetic Patients: Historic CohortCompletedNCT02486237
- Multi-centre Peer Support Program in Type 2 Diabetes Patients in Hong KongStatus unknownNCT02486172Not applicable
- Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of SulfonylureaTerminatedNCT02485132
- Saxagliptin and Cardiac Structure and FunctionCompletedNCT02481479Phase 4
- Efficacy and Safety of Lobeglitazone Versus SitagliptinStatus unknownNCT02480465Phase 4
- Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes PatientsCompletedNCT02479399
- A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Insulin 320 in Healthy SubjectsCompletedNCT02479022Phase 1
- Impact of a Regional Program Agir Sur Sa SantEActive, not recruitingNCT02478853
- ED Management of Severe Hyperglycemia: A Clinical TrialCompletedNCT02478190Not applicable
- Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With MetforminStatus unknownNCT02477969Phase 3
- Efficacy and Safety Study of PEX168 in Monotherapy Diabetes Mellitus Type 2 PatientsStatus unknownNCT02477865Phase 3
- Incretin-based Drugs and Acute PancreatitisCompletedNCT02476760
- Incretin-based Drugs and Pancreatic CancerCompletedNCT02475499
- Processed Meat and Brain Regions Related to Reward and AddictionCompletedNCT02474147Not applicable
- Minimal Psychological Intervention in Diabetes PatientsCompletedNCT02473081Not applicable
- Cut Down on Carbohydrate Usage in the Diet of Type 2 Diabetes - Mechanisms of Effective Therapy of Diabetes by Selective Choice of Macronutrients - The Phenotype StudyCompletedNCT02472951Not applicable
- Effect of Empagliflozin on Macrovascular and Microvascular Circulation and on Endothelium FunctionCompletedNCT02471963Phase 3
- Personalized Health Planning in Shared Medical Appointments for Individuals With Type II Diabetes Pilot StudyCompletedNCT02471794Not applicable
- Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic TherapyCompletedNCT02470039Phase 2
- Effect of Iron Reduction by Phlebotomy for Type 2 DiabetesCompletedNCT02468037Not applicable
- Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DMCompletedNCT02467920Phase 4
- Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal FunctionStatus unknownNCT02467790Phase 1
- The Role of Vitamin D3 and Calcium Supplementation in Attenuating T2DM SeverityCompletedNCT02464462Phase 1
- Treatment of Type 2 Diabetes With ImmunonutrientsCompletedNCT02462863Not applicable
- Diabetes Nutrition Algorithms in Patients With Overt Diabetes MellitusStatus unknownNCT02459496Not applicable
- Effect of Dapagliflozin on Glycemic VariabilityCompletedNCT02459353Phase 4
- Effect of AT-derived miRNA on the Biology and Insulin Sensitivity of Skeletal Muscle in HumansCompletedNCT02459106
- The Diabetes Medication Adherence Promotion Intervention TrialCompletedNCT02458495Not applicable
- Comparison of TIcagrelor and Clopidogrel in Patients With Coronary Artery diseaSe and Type 2 Diabetes Mellitus (TICS-DM)Status unknownNCT02457130Phase 4
- A Performance Evaluation of the Harmony 1 Sensors in Adults and PediatricsWithdrawnNCT02456922Not applicable
- Incretin-based Drugs and the Risk of Heart FailureCompletedNCT02456428
- Impact of a Program of Non-pharmacological Intervention in Patients With Type 2 Diabetes MellitusCompletedNCT02456064Not applicable
- Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes PatientsTerminatedNCT02456051
- Dose Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of REMD-477 in Subjects With Type 2 Diabetes MellitusCompletedNCT02455011Phase 1/2
- A Study to Assess the Efficacy and Safety of ASP1941 in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and SitagliptinCompletedNCT02452632Phase 3
- Evaluation of Pressure Distribution of Kyboot Shoes in Comparison to Other Foot WearCompletedNCT02451722Not applicable
- The Mobile Diabetes Mgmt. Study With Type 2 DiabetesStatus unknownNCT02451631Not applicable
- Metabolic and Hormonal Effects of 5:2 Intermittent FastingCompletedNCT02450097Not applicable
- Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 DiabetesCompletedNCT02449603Phase 4
- Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus StudyStatus unknownNCT02449330Phase 4
- A Biobehavioral Model of Diabetes Risk in Chinese ImmigrantsCompletedNCT02449213
- Evaluate the Pharmacokinetics of Simvastatin When Coadministered With PEX168 in Healthy Adult SubjectsCompletedNCT02447601Phase 1
- A Study to Evaluate the Effect of Musashino Diabetes Diet in Type II Diabetes Mellitus DiseaseCompletedNCT02446054Not applicable
- Effect of Bile Acid Secretion and Sequestration on GLP-1 SecretionCompletedNCT02445508Not applicable
- Effects of KDT501 on Metabolic Features in Insulin Resistant SubjectsCompletedNCT02444910Phase 2
- Effects of DPP-4 Inhibition on Calcium and Bone Metabolism in Type 2 Diabetes MellitusWithdrawnNCT02444364Early Phase 1
- Rowing Away From DiabetesCompletedNCT02444156Not applicable
- Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DMStatus unknownNCT02443922Not applicable
- Nutritional Therapy and Education With Multimedia Application in Patients With Type 2 DiabetesCompletedNCT02441023Not applicable
- Evaluation of the Targeted Screening of Type 2 Diabetes by Capillary Blood GlucoseCompletedNCT02440555
- Ghrelin and Beta Cell Function in DiabetesWithdrawnNCT02440061Phase 1
- the Efficacy of Acarbose and Metformin on Blood Glucose Fluctuation When Combined With Premix InsulinStatus unknownNCT02438397Phase 4
- Pharmaceutical Care Program for Type 2 Diabetes MellitusCompletedNCT02435693Not applicable
- Microcirculation and Bone Metabolism in Patients With Type 2 Diabetes Mellitus and Charcot Foot - A Pilot StudyCompletedNCT02435329
- Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes MellitusCompletedNCT02434744Phase 2
- Using Combined Instantaneous and Multidimensional Feedback to Support a Change in Physical Activity BehaviourCompletedNCT02432924Not applicable